搜索临床试验以:警报“AFNOR 3.6”。
总计1152个结果
-
Brigham and Women's HospitalDaiichi Sankyo, Inc.完全的
-
Li Zhang, MD招聘中诊断为 ALK 阳性 NSCLC | 第二代 ALK-TKI 耐药 | Ensatinib 在这部分患者中的疗效中国
-
Eisai Inc.完全的
-
Shin Kong Wu Ho-Su Memorial HospitalNational Taipei University of Nursing and Health Sciences招聘中
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)完全的
-
Jeffrey S HeierKato Pharmaceuticals, Inc.完全的
-
Scott C. Woller, MDJanssen Pharmaceuticals尚未招聘
-
University of Texas Southwestern Medical CenterUS Department of Veterans Affairs完全的
-
National Cancer Institute (NCI)完全的
-
Maastricht University Medical CenterDutch Heart Foundation; Center for Translational Molecular Medicine完全的
-
University of MichiganAgency for Healthcare Research and Quality (AHRQ)招聘中
-
Bahceci Health GroupUskudar University未知
-
University Hospital TuebingenEuropean Space Agency; Dr. Isabelle Mack, Co-PI, University Hospital Tübigen; Dr. Claude Lambert... 和其他合作者招聘中
-
Brigham and Women's HospitalPortola Pharmaceuticals招聘中
-
Hasan Kalyoncu University完全的
-
Rio de Janeiro State UniversityUniversidade Federal Fluminense; Rio de Janeiro State Research Supporting Foundation (FAPERJ)招聘中
-
Technical University of MunichCharite University, Berlin, Germany; Translationales intensivmedizinisches Forschungsnetzwerk...完全的
-
Shire完全的
-
Pearl Therapeutics, Inc.完全的慢性阻塞性肺疾病美国, 奥地利, 比利时, 加拿大, 丹麦, 德国, 意大利, 西班牙, 瑞典, 英国, 秘鲁, 巴西, 南非, 阿根廷, 俄罗斯联邦, 墨西哥, 波多黎各, 智利, 挪威
-
Kanuni Sultan Suleyman Training and Research Hospital主动,不招人
-
Instituto Nacional de Saúde, MozambiqueUNITAID; Clinton Health Access Initiative Inc.; UNICEF完全的